Keywords: zeltia, gets, million, payment, spanish, firm, says
Zeltia gets $6 million payment from J&J
Article | 01 July 2002
Spanish firm Zeltia says that its biotechnology subsidiary Pharma Maris to receive $6 million from partner Johnson & Johnson, having achieved milestones ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
